Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
Astellas Needs To Pick A Model To ProsperStephen Simpson • Thu, Feb 21
-
India Markets Wednesday Wrap-Up: No Respite From Selling PressureEquitymaster • Wed, May 25, 2011
-
Similarities Between the First Two Active Immunotherapies in CancerMichael Becker • Wed, Mar 30, 2011
-
Astellas Buyout of OSI Pharmaceuticals Gets More LikelyDerek Lowe • Wed, May 19, 2010
-
Monday Options RecapFrederic Ruffy • Mon, Mar 15, 2010
-
Astellas Needs To Pick A Model To ProsperStephen Simpson • Thu, Feb 21
-
Astellas Needs To Pick A Model To ProsperStephen Simpson • Thu, Feb 21
-
India Markets Wednesday Wrap-Up: No Respite From Selling PressureEquitymaster • Wed, May 25, 2011
-
Similarities Between the First Two Active Immunotherapies in CancerMichael Becker • Wed, Mar 30, 2011
-
Astellas Buyout of OSI Pharmaceuticals Gets More LikelyDerek Lowe • Wed, May 19, 2010
-
Monday Options RecapFrederic Ruffy • Mon, Mar 15, 2010
There are no Transcripts on ALPMY.PK.
There are no News articles on ALPMY.PK.
ALPMY.PK vs. ETF Alternatives
Company Description
Currently, there's no company description for ALPMY.PK.